prognostic indicators

Research in Review
Five-Factor Risk Assessment Identifies Patients Who Most Benefit from Bevacizumab Treatment
12/23/2015
JCP Editors
Cervical cancer patients categorized as mid- or high-risk using the Moore criteria can benefit from adding bevacizumab to their chemotherapy regimen, according to a new study published in Clinical Cancer Research....
Cervical cancer patients categorized as mid- or high-risk using the Moore criteria can benefit from adding bevacizumab to their chemotherapy regimen, according to a new study published in Clinical Cancer Research....
...
12/23/2015
Journal of Clinical Pathways
Research in Review
New MRI Technique Non-invasively Detects Biomarker for Lung Cancer
12/11/2015
JCP Editors
Researchers from Georgia State University, Atlanta, have developed a new imaging technique to better track cancer progression of the lung and prostate, according to a study published in Scientific Reports. The team,...
Researchers from Georgia State University, Atlanta, have developed a new imaging technique to better track cancer progression of the lung and prostate, according to a study published in Scientific Reports. The team,...
...
12/11/2015
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
LLM Winter Symposium
February 7 ⁠–⁠ February 9
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
GD Solid Tumors
March 22 ⁠–⁠ March 23
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 4
WoundCon
May 1 ⁠–⁠ May 3
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use